Arrowstreet Capital, Limited Partnership Astrazeneca PLC Put Options Transaction History
Arrowstreet Capital, Limited Partnership
- $114 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AZN
# of Institutions
1,357Shares Held
493MCall Options Held
5.1MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$4.23 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.74 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$2.64 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.39 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA19.3MShares$1.26 Billion0.43% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $202B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...